|
|
||||||||
A-Expressing Human Lens Epithelial Cell Lines and in
A Knockout Mouse Lenses
1 From the Division of Gastrointestinal and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles; 2 National Eye Institute, Bethesda, Maryland; and 3 Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri.
PURPOSE. To study the mechanism of regulation of GSH in HLE-B3 cells expressing
A-crystallin (
A) and in
A knockout mouse lenses.
METHODS. GSH levels and maximal rates of GSH synthesis were measured in
immortalized,
A-transfected HLE-B3 cells containing varying amounts
of
A. The mRNA and protein for the rate-limiting enzyme for GSH
synthesis,
-glutamylcysteine synthetase (GCS), were also determined
in
A- and mock-transfected cells by Northern blot analysis and
Western blot analysis of heavy (GCS-HS) and light (GCS-LS) subunits.
The effect of absence of
A and
B on lens GSH concentrations was
evaluated in whole lenses of
A knockout and
B knockout mice as a
function of age. GCS-HS mRNA and protein were determined in young,
precataractous and cataractous
A knockout lenses.
RESULTS. GSH levels were significantly higher in HLE-B3 cells expressing
A-
compared with mock-transfected cells and were correlated positively
with
A content. Mean rate of GSH synthesis was also higher in
A-expressing cells than in mock controls (0.84 vs. 0.61 nmol ·
min-1 per mg protein, respectively). GCS-HS mRNA and
GCS-LS mRNA were approximately twofold higher in
A-expressing cells,
whereas the heavy and light GCS subunit proteins increased by 80% to
100%. In
A(-/-) mouse lenses, GSH level was not different
from that of wild type up to 2 months from birth, after which it
dropped to
50% of controls. On the other hand, GCS-HS and GCS-LS
proteins showed a significant decrease before cataract formation as
early as 15 days after birth. GSH level in cataract-free
B(-/-)
lenses was similar to that of wild type for up to 14 months.
CONCLUSIONS. Expression of
A caused an increase in cellular GSH, in part, because
of an increase in mRNA and protein of both GCS subunits. GSH levels
decreased with increasing age in cataractous
A(-/-) lenses but not
in the noncataractous
B(-/-) lenses. It is suggested that neonatal
precataractous lenses (with normal GSH and decreased GCS) may maintain
their GSH level by other compensatory mechanisms such as increased GSH
transport.
This article has been cited by other articles:
![]() |
L. E. Morrison, R. J. Whittaker, R. E. Klepper, E. F. Wawrousek, and C. C. Glembotski Roles for {alpha}B-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H847 - H855. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choudhary, S. Srivastava, T. Xiao, U. P. Andley, S. K. Srivastava, and N. H. Ansari Metabolism of Lipid Derived Aldehyde, 4-Hydroxynonenal in Human Lens Epithelial Cells and Rat Lens Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2675 - 2682. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Gukasyan, R. Kannan, V. H. L. Lee, and K.-J. Kim Regulation of L-Cystine Transport and Intracellular GSH Level by a Nitric Oxide Donor in Primary Cultured Rabbit Conjunctival Epithelial Cell Layers Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1202 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Gukasyan, V. H. L. Lee, K.-J. Kim, and R. Kannan Net Glutathione Secretion across Primary Cultured Rabbit Conjunctival Epithelial Cell Layers Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1154 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Nees, E. F. Wawrousek, W. G. Robison Jr, and J. Piatigorsky Structurally Normal Corneas in Aldehyde Dehydrogenase 3a1-Deficient Mice Mol. Cell. Biol., February 1, 2002; 22(3): 849 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Brady, D. L. Garland, D. E. Green, E. R. Tamm, F. J. Giblin, and E. F. Wawrousek {alpha}B-Crystallin in Lens Development and Muscle Integrity: A Gene Knockout Approach Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2924 - 2934. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |